Strengthening circadian signals to enhance cardiometabolic function
加强昼夜节律信号以增强心脏代谢功能
基本信息
- 批准号:10178077
- 负责人:
- 金额:$ 68.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Activity CyclesAcuteAdultAnimalsArousalBasal metabolic rateBehaviorBehavioralBiochemicalBiological AssayBiologyBlood PressureBody mass indexCardiometabolic DiseaseCardiovascular DiseasesChronic DiseaseCircadian DysregulationCircadian RhythmsClinical ResearchClinical TrialsCoupledDataDevelopmentDiabetes MellitusDiseaseDoseElderlyElementsEnergy IntakeEnrollmentExposure toFastingFeeding behaviorsFutureGenesGenetic PolymorphismHealthHigh PrevalenceHormonalHourHumanHydrocortisoneHypertensionInterventionKnowledgeLaboratory StudyLightLinkLongevityMeasuresMelatoninMelatonin ReceptorsMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMg supplementationMolecularMutationNon-Insulin-Dependent Diabetes MellitusOGTTObesityOrganOutcome MeasureOverweightPathogenesisPatternPeriodicityPeripheralPhysical activityPhysical environmentPhysiologicalPolysomnographyPrevalencePreventionPrevention strategyReceptor GeneRegimenRegulatory PathwayRestRiskRisk FactorsRoleSignal TransductionSleepSleep Wake CycleSlow-Wave SleepSocial EnvironmentTestingTherapeutic InterventionTimeTissuesTranslatingWeightWhole Organismactigraphyadult obesitybasecardiometabolic riskcardiometabolismcardiovascular risk factorcircadiancircadian pacemakercircadian regulationdesigndiabetes riskdisorder riskexperiencefeedingfield studyheart rate variabilityimprovedindexinginnovationinsightinterestmelatonin supplementationmiddle agenon-diabeticnovelobesity treatmentplacebo controlled studyprimary outcomeprogramsresponsesleep onsetsleep physiologysleep qualitytreatment arm
项目摘要
PROJECT SUMMARY
There is a growing body of evidence from both laboratory and field studies that disrupted circadian function,
particularly decreased amplitude and stability of rhythmic behaviors represent significant risk factors for
cardiometabolic disease (CMD) in humans. The exciting evidence of the ubiquity of circadian clocks in all tissues
and their critical role in metabolism, not only opens up new avenues for understanding the mechanistic
interactions between central and peripheral clocks in cardiometabolic disease pathogenesis, but also to develop
therapeutic interventions to re-establish synchrony between central and peripheral clocks with each other and
with the external physical and social environments. Feeding has been shown to synchronize clocks in peripheral
tissues. Animal studies have demonstrated that restricting feeding to the active period decreases CMD risk, while
in humans decreased caloric intake in the evening is associated with a lower body mass index (BMI). The
amplitude of melatonin can be considered a marker of robustness of central circadian function, but melatonin
also has physiological effects beyond circadian regulation throughout the body. Recent observations have
demonstrated that having a low melatonin level is a risk factor for incident diabetes and hypertension
independent of sleep duration. Together, the evidence suggests that strategies aimed at synchronizing feeding
behavior and enhancing the nocturnal melatonin signal can positively impact cardiometabolic function. We
propose to take an innovative approach that combines the recent data on the role of feed/fast patterns on clock
regulated metabolic activity and the reemergence of scientific interest of the central and peripheral effects of
melatonin on cardiometabolic function to elucidate the physiological and molecular mechanisms that underlie
the relationship between circadian dysregulation and obesity associated CMD risk. This will be accomplished by
strengthening the amplitude of circadian metabolic signals via extended overnight fasting (EOF) and
enhancement of nocturnal circadian signaling with exogenous melatonin in overweight and obese middle aged
and older adults. In addition, this study will provide crucial information regarding the importance of circadian
timing for the design of future clinical trials on CMD in overweight and obese adults. This is a critical time in the
lifespan when circadian based strategies for prevention and treatment are most likely to have the greatest impact
on CMD risk. This project will enroll 100 adults (40-65 years) to participate in a parallel (4 arm intervention)
placebo controlled study to determine whether a six- week program of extended overnight fasting (EOF) of 12-
14 hours and/or low dose (3 mg) melatonin administration will enhance circadian amplitude and enhance
cardiometabolic function, as well as to evaluate the potential beneficial effects of a regimen that combines both
approaches. The results from this study will demonstrate novel mechanistically based approaches for
maintaining and improving circadian-metabolic health during a critical time in the lifespan when there is a rapid
increase in the prevalence of CMD.
项目总结
越来越多的证据来自实验室和现场研究,这些证据扰乱了昼夜节律功能,
特别是节律性行为的幅度和稳定性降低是
人类的心脏代谢疾病(CMD)。生物钟在所有组织中普遍存在的令人兴奋的证据
以及它们在新陈代谢中的关键作用,不仅为理解
心脏代谢性疾病发病机制中中枢和外周时钟的相互作用
治疗干预以重建彼此之间的中央和外围时钟之间的同步性
与外部物理和社会环境的关系。研究表明,喂食可以使外设的时钟同步
纸巾。动物研究表明,将喂养限制在活动期可以降低CMD的风险,而
在人类中,晚上卡路里摄入量减少与较低的体重指数(BMI)有关。这个
褪黑素的幅度可以被认为是中枢昼夜节律功能强健的标志,但褪黑素
也有生理上的影响,超越了整个身体的昼夜节律。最近的观察表明
证明褪黑激素水平低是糖尿病和高血压的危险因素
与睡眠时间无关。总而言之,证据表明,旨在同步进食的策略
行为和夜间增强褪黑素信号可以积极地影响心脏代谢功能。我们
建议采用一种创新的方法,将有关馈送/快速模式在时钟上的作用的最新数据结合起来
受调节的代谢活动和对中枢和外周效应的科学兴趣的重新出现
褪黑素对心脏代谢功能的影响
昼夜节律失调与肥胖相关的CMD风险的关系。这将通过以下方式实现
通过延长隔夜禁食(EOF)和
外源性褪黑素对超重肥胖中年人夜间昼夜节律信号的增强作用
以及年长的成年人。此外,这项研究将提供有关昼夜节律重要性的重要信息。
设计未来针对超重和肥胖成年人的CMD临床试验的时机。这是一个关键的时刻
基于昼夜节律的预防和治疗策略最有可能产生最大影响的寿命
关于CMD风险。该项目将招募100名成年人(40-65岁)参加平行的(4个手臂干预)
一项安慰剂对照研究,旨在确定一项为期六周的延长通宵禁食(EOF)计划是否对
14小时和/或小剂量(3毫克)褪黑素可增强昼夜节律幅度并增强
心脏代谢功能,以及评估两者相结合的方案的潜在有益影响
接近了。这项研究的结果将展示基于机械的新方法
在生命中的关键时期维持和改善昼夜节律代谢健康
慢性阻塞性肺疾病患病率增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Phyllis C. Zee其他文献
Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: emJACC/em State-of-the-Art Review
阻塞性睡眠呼吸暂停与心血管疾病病理生理学的相互作用,第1部分:《美国心脏病学会杂志》(*JACC*)前沿综述
- DOI:
10.1016/j.jacc.2024.02.059 - 发表时间:
2024-09-24 - 期刊:
- 影响因子:22.300
- 作者:
Shahrokh Javaheri;Sogol Javaheri;Virend K. Somers;David Gozal;Babak Mokhlesi;Reena Mehra;Walter T. McNicholas;Phyllis C. Zee;Francisco Campos-Rodriguez;Miguel Angel Martinez-Garcia;Peter Cistulli;Atul Malhotra - 通讯作者:
Atul Malhotra
Serotonin in the spotlight
血清素成为焦点
- DOI:
10.1038/385123a0 - 发表时间:
1997-01-09 - 期刊:
- 影响因子:48.500
- 作者:
Plamen D. Penev;Phyllis C. Zee;Fred W. Turek - 通讯作者:
Fred W. Turek
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: emJACC/em State-of-the-Art Review
阻塞性睡眠呼吸暂停的治疗及其对心血管疾病的影响,第2部分:《美国心脏病学会杂志》(emJACC/em )前沿综述
- DOI:
10.1016/j.jacc.2024.07.024 - 发表时间:
2024-09-24 - 期刊:
- 影响因子:22.300
- 作者:
Shahrokh Javaheri;Sogol Javaheri;David Gozal;Francisco Campos-Rodriguez;Miguel Angel Martinez-Garcia;Babak Mokhlesi;Reena Mehra;Walter T. McNicholas;Virend K. Somers;Phyllis C. Zee;Peter Cistulli;Atul Malhotra - 通讯作者:
Atul Malhotra
Characteristics of objectively-measured naturalistic light exposure patterns in U.S. adults: A cross-sectional analysis of two cohorts
美国成年人客观测量的自然采光模式特征:两个队列的横断面分析
- DOI:
10.1016/j.scitotenv.2025.178839 - 发表时间:
2025-03-15 - 期刊:
- 影响因子:8.000
- 作者:
Danielle A. Wallace;Kelly R. Evenson;Carmen R. Isasi;Sanjay R. Patel;Daniela Sotres-Alvarez;Phyllis C. Zee;Susan Redline;Frank A.J.L. Scheer;Tamar Sofer - 通讯作者:
Tamar Sofer
Treatment of Shift Work Disorder and Jet Lag
- DOI:
10.1007/s11940-010-0090-9 - 发表时间:
2010-07-20 - 期刊:
- 影响因子:1.800
- 作者:
Phyllis C. Zee;Cathy A. Goldstein - 通讯作者:
Cathy A. Goldstein
Phyllis C. Zee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Phyllis C. Zee', 18)}}的其他基金
THE NEURAL RESPONSE TO SLEEP LOSS IN THE ELDERLY
老年人对睡眠不足的神经反应
- 批准号:
7604243 - 财政年份:2006
- 资助金额:
$ 68.29万 - 项目类别:
LIGHT-INDUCED SUPPRESSION OF MELATONIN IN ADVANCED AND DELAYED SLEEP
提前和延迟睡眠中光诱导的褪黑激素抑制
- 批准号:
7604273 - 财政年份:2006
- 资助金额:
$ 68.29万 - 项目类别:
SLEEP-RELATED ENDOCRINE PROFILES IN SUBJECTS WITH CIRCADIAN PHASE DISORDERS
昼夜节律时相紊乱受试者的睡眠相关内分泌特征
- 批准号:
7604267 - 财政年份:2006
- 资助金额:
$ 68.29万 - 项目类别:
SLEEP-RELATED ENDOCRINE PROFILES IN SUBJECTS WITH CIRCADIAN PHASE DISORDERS
昼夜节律时相紊乱受试者的睡眠相关内分泌特征
- 批准号:
7376862 - 财政年份:2005
- 资助金额:
$ 68.29万 - 项目类别:
AGE RELATED EFFECTS OF SLEEP DEPRIVATION ON CEREBRAL CORTICAL ACTIVITATION
睡眠剥夺对大脑皮层激活的年龄相关影响
- 批准号:
7376829 - 财政年份:2005
- 资助金额:
$ 68.29万 - 项目类别:
LIGHT-INDUCED SUPPRESSION OF MELATONIN IN ADVANCED AND DELAYED SLEEP
提前和延迟睡眠中光诱导的褪黑激素抑制
- 批准号:
7376871 - 财政年份:2005
- 资助金额:
$ 68.29万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 68.29万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 68.29万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 68.29万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 68.29万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 68.29万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 68.29万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 68.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 68.29万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 68.29万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 68.29万 - 项目类别:














{{item.name}}会员




